Escalating microbial resistance drives the development of next-generation antibacterial agents, with Schiff base-lanthanide complexes emerging as promising candidates due to their novel modes of action.
Paswan et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: